That timeframe would make Pfizer's vaccine an alternative to antibody-based therapies that are given not to the mother, but to the infants themselves, to protect against RSV in the crucial first ...

Pfizer is also testing its vaccine for prevention of RSV infection in infants from birth up to six months by vaccinating pregnant women in the MATISSE trial, which is also due to generate results ...

RSV is a contagious virus causing severe respiratory infections in infants. Vaccination during pregnancy, provides newborns ...

Expectant mothers will have access to free vaccines against respiratory syncytial virus (RSV) from next month under a major ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

Vulnerable and elderly Australians are missing out on protection against respiratory syncytial virus (RSV) because many can’t ...

The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...

Studies have shown that children and preterm infants infected with RSV who ... was involved in the clinical trials for the Pfizer RSV vaccine, the GSK RSV vaccine (which was terminated), as ...

The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...

Pregnant women will be offered free RSV vaccines as part of the National Immunisaton Program from February 3, Health Minister ...

Pfizer said it will 'support capacity-building initiatives, such as training healthcare professionals and advancing clinical ...